Elanco Animal Health Inc (ELAN) stock
ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$26.70+0.85 (+3.29%)
Close on Nov 18, 2026Market cap $13.34BP/E –Yield –
Elanco Animal Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Elanco Animal Health's enterprise value was $16.62B on Nov 11, 2026, against $15.08B a year earlier. Over the last 5 years it ranged from $8.54B to $19.31B, with a median of $12.78B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.62B | +12.6% |
| 2025 | Dec 31, 2025 | $14.76B | +49.8% |
| 2024 | Dec 31, 2024 | $9.85B | -23.5% |
| 2023 | Dec 29, 2023 | $12.88B | +14.7% |
| 2022 | Dec 30, 2022 | $11.23B | -41.8% |
| 2021 | Dec 31, 2021 | $19.31B | -3.2% |
| 2020 | Dec 31, 2020 | $19.95B | +53.1% |
| 2019 | Dec 31, 2019 | $13.04B | -4.9% |
| 2018 | Dec 31, 2018 | $13.71B | – |
See a number that looks wrong?